Noblyst® P

MaxiPure® Polysorbate 80 is a non-ionic surfactant. It is manufactured from highly pure oleic acid (≥98%), ensuring minimal impurities compared to standard grades. MaxiPure® Polysorbate 80 has reduced peroxide levels and water content, resulting in outstanding clarity.

In injectable formulations, Po...

Northern Lipids® is a brand that Evonik uses to represent the company's comprehensive lipid portfolio, which is a cornerstone in the market for advanced drug delivery systems. 

Evonik is a global leader in contract development and manufacturing (CDMO) services for lipid-based parenteral drug de...

PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regul...

EUDRACAPTM functional ready-to-fill capsules can optimize your release profile, protect your active ingredients, and help accelerate your speed to market. EUDRACAP™ is ideal for use with active ingredients which are sensitive to heat, moisture or gastric acid to optimize absorption and avoid premature ...

Evonik offers a new solubility enhancement technology and service package for small molecules used in oral drugs that are particularly challenging to dissolve. EUDRATEC® SoluFlow is the latest addition to Evonik’s platform of oral drug delivery technologies for targeted release. This process technology and...

Evonik is a global development partner and solutions provider for oral drug delivery. For more than 70 years, we have been providing renowned pharmaceutical and biotech companies with oral drug delivery solutions to help them enhance drug performance, reduce project complexity, increase speed to market and...

Evonik is one of the world’s leading CDMOs for parenteral drug delivery. For complex parenteral drug products designed for systemic, targeted or localized delivery, we are uniquely positioned to serve as a global development partner and solutions provider. Our parenteral drug delivery portfolio includes th...

Plant-derived cholesterol for mRNA delivery, gene therapy and cell culture: Our plant-derived PhytoChol® provides you with a secure and stable supply of synthetic cholesterol. Evonik supplies PhytoChol® in two grades that are tailored to the specific needs of injectable drug delivery and biopharm...

Evonik has over three decades of experience formulating liposomes and lipid nanoparticles (LNPs) using variety of different lipids. Evonik also manufactures lipids, including those used in mRNA COVID-19 vaccines. We harbor a deep understanding of liposomes and LNPs, including formulation, scale up, and ...

Lipid nanoparticles (LNPs) enable the delivery of a variety of molecules, including nucleic acids such as mRNA, to cells and are therefore an essential tool in gene therapy. To unleash the potential of vaccines, protein and gene therapies, drug developers need the support of a trusted and experienced pro...

cQrex IS THE EVONIK BRAND FOR CELL CULTURE SOLUTIONS WITH SCIENTIFICALLY PROVEN BENEFITS
• Highly purified amino acids: the reliable basis forreproducible cell culture media performance
• Chemically defined boosters: peptides and ketoacidsovercoming key challenges in mammalian cell culture
•...

Evonik is a global leader in Contract Development and Manufacturing (CDMO) for active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, including high-potency APIs (HPAPIs). With decades of experience in custom synthesis, drug development, and process optimization, we support pharmaceutic...

In this series of interviews, we speak to the teams behind the winning concepts at CPHI Pharma Awards 2022, which was held at CPHI Frankfurt, across the categories from digital innovation to CEO of the year. 

PhytoSquene® is the world’s first GMP-quality, plant-derived squalene. It offers a sustainable and high-quality alternative to traditional shark-derived squalene, meeting the need for sustainably sourced pharmaceutical-grade squalene. The key drivers behind its development are sustainability, safety, regulatory compliance and social responsibility. Extracting squalene from shark livers for use in parenteral pharmaceutical applications such as vaccines depletes shark populations, which impacts marine biodiversity. PhytoSquene® supports the UN Sustainable Development Goals (SDGs) of protecting ecosystems and promoting circularity, while also mitigating risks associated with bioaccumulative toxins found in animal sources, and ensuring batch-to-batch consistency and superior quality in compliance with European Pharmacopoeia standards. Made from amaranth oil and manufactured in Germany using proprietary technology, PhytoSquene® not only advances patient safety and acceptance, but also demonstrates Evonik’s commitment to next-generation solutions with a positive sustainability profile. PhytoSquene® provides vaccine manufacturers and patients peace of mind while protecting marine ecosystems.